FNA Paragon 28 Projected Price to Earnings

Brandmark of Paragon 28, Inc. (FNA)

Through unique surgical protocols, Paragon 28, Inc. (FNA) ensures total physician loyalty while scaling B2B implant supplies to surgical centers. The company's forward P/E dynamics clearly illustrate the market valuation, where the 0.00 mark serves as a key metric. Specializing in high-tech foot and ankle solutions allows the issuer to effectively minimize risks, securing a stable niche within the medical sector.

FNA - Paragon 28, Inc. Projected Price to Earnings Ratio over the range 07/04/2022 - 04/26/2025

Financial and market metric breakdowns for paragon28.com (FNA)

- stock quotes and analyst forecast:
Fundamental company analysis:Paragon 28
Product sample of Paragon 28, Inc.

The high margins on Paragon 28, Inc. (FNA) implants create a steady cash flow that should be reflected in the market valuation. The projected P/E dynamics for the company on GURU.Markets compare the current share price with expected earnings, allowing investors to distinguish fundamental undervaluation from a systemic business decline. Analyzing this multiple helps determine the asset's fair value based on consensus forecasts of future income.

Competitors of Paragon 28, Inc. (FNA)

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings AORT (Artivion)|ENOV (Enovis Corp) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Inc. IART|ESTA - Projected Price to Earnings|Beta Bionics, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED CORPORATION|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen Surgical) - Forward P/E Multiple|SI-BONE Corp (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Forward P/E Multiple bioventus.com (BVS)|Forward P/E Multiple KIDS (OrthoPediatrics Corp)|Forward P/E Multiple Treace Medical Concepts Inc TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight, Inc.) - Projected Price to Earnings|ClearPoint Neuro Inc. - Future Price to Earnings Multiple|STXS (Stereotaxis Corporation) - Forward P/E Multiple|Projected Price to Earnings Ratio Neuronetics Inc. STIM|Future Price to Earnings Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Forward Price to Earnings Multiple|Anika Therapeutics Inc. - Projected Price to Earnings|Forward P/E Multiple InspireMD, Inc. NSPR|Jin Medical International Ltd. - Forward P/E Multiple|Market Cap to Projected Earnings Vivani Medical VANI|Xtant Medical (XTNT) - Future Price to Earnings|Price to Expected Earnings Ratio NMTC (NeuroOne Medical Technologies Corp.)|Future Price to Earnings modular-medical.com|Projected Price to Earnings Ratio myomo.com MYO|Forward P/E Multiple COCH|VVOS - Projected Price to Earnings Ratio|Future Price to Earnings enVVeno Medical NVNO|SINT: Price to Future Earnings Ratio|TNON: Projected Price to Earnings|rewalk.com - Market Cap to Future Earnings Ratio|AMIX: Forward P/E Multiple|Price to Future Earnings Ratio IVF|Future Price to Earnings bonebiologics.com|Price to Future Earnings Ratio AXNX (Axonics, Inc)|Future Price to Earnings BIOLASE Inc. (BIOL)|Dynatronics - Price to Future Earnings Ratio|Future Price to Earnings INVO Bioscience INVO